Digging into 'the rabbit-hole' of the extracellular matrix by Burgstaller, Gerald
E-Mail karger@karger.com
 Editorial Comment 
 Respiration 2015;89:15–16 
 DOI: 10.1159/000369473 
 Digging into ‘the Rabbit-Hole’ of the 
Extracellular Matrix 
 Gerald Burgstaller  
 Comprehensive Pneumology Center, University Hospital of the Ludwig Maximilians University Munich and 
Helmholtz Zentrum München, Member of the German Center for Lung Research,  Munich , Germany 
mentally influence the behavior of cells finally resulting 
in a pathological vicious circle. The ECM parameters that 
might provoke a cellular reaction can be manifold: mo-
lecular composition, 3-dimensional architecture, fiber 
size and orientation, topology, stiffness or viscoelastici-
ty, posttranslational modifications or matrix-associated 
growth factors. Booth et al.  [4] demonstrated that, in the 
human lung, fibroblasts that were reseeded on fibrotic 
decellularized lung matrices derived from patients with 
idiopathic pulmonary fibrosis (PF) differentiate into 
αSMA-expressing myofibroblasts mostly by means of a 
TGF-β-independent mechanism  [4] , i.e. they attribute 
mechanisms that backfire to the biophysical properties 
of the ECM rather than to soluble inflammatory and fi-
brogenic mediators. This finding is supported by several 
studies in different settings  [5–9] . Laurent et al.  [10] re-
viewed the role of soluble mediators in disease, based on 
aberrant remodeling of the ECM. Wagner et al.  [11] re-
cently managed to show that human cells (i.e. bronchial 
epithelial cells, lung fibroblasts and mesenchymal stem 
cells), when reseeded on emphysematous decellularized 
lung scaffolds, did not persist past day 7. In contrast, on 
normal decellularized lung scaffolds, the same type of 
cells were found to be viable for up to 28 days in culture. 
Interestingly, when the same cells were cultured on plas-
 In its physiological context, the extracellular matrix 
(ECM) is a complex and highly ordered 3-dimensional 
meshwork of numerous fibrous and nonfibrous mole-
cules. Its function lies far beyond mere architectural sup-
port for the anchorage of a tissue’s cellular components. 
Biochemical and biophysical cues within the ECM are 
thought to steer biological processes like tissue homeo-
stasis and morphogenesis as well as cellular differentia-
tion, proliferation, survival and migration  [1, 2] . By and 
large, the ECM is composed of mostly huge and complex 
macromolecules such as collagens, elastin, proteogly-
cans, fibronectins and laminins. When analyzing these 
molecules experimentally, their large size, insolubility 
and degree of cross-linking pose huge challenges. Never-
theless, attempts to decipher the protein composition of 
human and mouse ECM in much more detail by combin-
ing bioinformatics and in vivo confirmation with mass 
spectrometry-based proteomic technology have been 
quite successful, revealing the matrisome of the murine 
lung  [3] . Thus, in future, it will become more and more 
common to decipher the proteomic composition (‘ma-
trisome signature’) of the ECM by proteomic techniques 
in physiological and pathological processes. To date, it is 
still unclear whether instructive cues within the ECM 
could, along with a plethora of secreted mediators, detri-
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 You take the red pill – you stay in Wonderland and I 
show you how deep the rabbit-hole goes.






tic dishes coated with solubilized matrix derived from 
emphysematous decellularized lung, no cytotoxic effects 
were observed. This strongly favors the existence of per-
nicious cues residing within the 3-dimensional micro- 
and macro-architecture of the diseased ECM rather than 
in its molecular composition alone. An aberrant remod-
eling of the ECM is a hallmark of various lung diseases. 
In fibrotic interstitial lung diseases, such as idiopathic 
PF, the massive secretion of ECM proteins strongly de-
teriorates the compliance of the lung tissue. In addition, 
the ECM proteins are subjected to multiple posttransla-
tional modifications (PTMs) that may have different
activation patterns in the pathological state and thus
contribute to the progression of disease. In the latest is-
sue of  Respiration , Kristensen et al.  [12]  review the PTMs 
(glycosylation, proteolytic cleavage, cross-linking, oxi-
dation and citrullination) that most commonly affect 
ECM quality, thus contributing to the biophysics and 
biomechanics of the ECM in idiopathic PF. PTMs can be 
manifold and highly variable in different diseases or even 
in various stages of a disease, so deciphering the role of 
PTM signatures (‘protein quality’) will become as impor-
tant as assessing the amount and composition of secreted 
ECM proteins (‘protein quantity’) in the onset and pro-
gression of PF. As reviewed by Kristensen et al.  [12] , pro-
teolytically fragmented collagen and elastin molecules 
might, in the future, be a novel source of valid biomark-
ers with diagnostic and prognostic value with respect to 
customized treatments for idiopathic PF and chronic ob-
structive pulmonary disease patients. Prospectively, an 
understanding of the complex molecular and biophysical 
interplay between cells and the inherent instructive cues 
of natural ECM might aid the development of a surrogate 
ECM, either synthetic or natural, that could ultimately 
provide new and transplantable tissues. Furthermore, 
the emergence of sensitive and automated high-through-
put proteomic techniques that are capable of readily de-
tecting the signatures of both ‘protein quantity and qual-
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